Movement Alert|Medline Inc. Pre-Market Rise 7.8%, third-quarter results beat expectations

Market Focus11-04

On November 4, Medline Inc. rose 7.8% in Pre-Market Trading, trading at $36.75/share, with turnover of $4.264 million.

The move followed a quarterly earnings release that exceeded market expectations on both profit and revenue.

For the fiscal third quarter, adjusted EPS was $0.44 versus the $0.35 consensus estimate, while sales reached $7.856 billion versus the $7.723 billion consensus. Net sales also increased from $7.12 billion a year earlier to $7.86 billion, indicating continued growth across its medical-surgical products and supply chain solutions businesses.

Recent context has been mixed: Medline had disclosed a broad removal or correction program for certain branded beds and accessories tied to fire and patient-entrapment risks, while it also introduced an enhanced TrackPoint system for long-term care providers in October. In the current session, however, the earnings beat appears to be the clearest direct catalyst for the stock’s pre-market strength.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment